Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
11/02/2022* -- Results Q3 2022 -- 0.73 --
11/02/2022* 08:30 EST Earnings Call Q3 2022 -- -- --
07/27/2022 08:30 EST Earnings Call Q2 2022 -- -- --
07/27/2022 -- Results Q2 2022 0.82 0.80 2.59%
04/27/2022 -- Results Q1 2022 0.74 0.68 8.94%
04/27/2022 08:30 EST Earnings Call Q1 2022 -- -- --
02/23/2022 -- Results Q4 2021 0.84 0.84 0.44%
02/23/2022 08:30 EST Earnings Call Q4 2021 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 11/02/2022 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 07/27/2022
Beat/Miss Upgrade
Return Since -22.89%
Last FQE 06/30/2022
Next FQE 09/30/2022

Profile

Edit
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopaedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and orthopaedics and tissue technologies. Codman specialty surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific and the rest of the world whilst it derives key revenue from domestic sales.
URL https://www.integralife.com
Investor Relations URL https://investor.integralife.com/
HQ State/Province New Jersey
Sector Healthcare
Industry Medical Devices
Equity Style Small Cap/Blend
Next Earnings Release Nov. 02, 2022 (est.)
Last Earnings Release Jul. 27, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0.00%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
38.28%
26.57%
11.57%
-5.77%
29.22%
11.39%
3.19%
-34.93%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-21.61%
--
--
--
--
--
136.2%
71.93%
41.36%
--
38.92%
-25.22%
119.0%
-3.03%
38.17%
-40.95%
13.39%
-67.80%
-28.59%
-49.84%
-47.69%
-93.17%
229.0%
-48.60%
-38.08%
-87.17%
63.37%
16.67%
-79.93%
-17.17%
8.91%
-45.97%
-70.79%
As of September 23, 2022.

Profile

Edit
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopaedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and orthopaedics and tissue technologies. Codman specialty surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific and the rest of the world whilst it derives key revenue from domestic sales.
URL https://www.integralife.com
Investor Relations URL https://investor.integralife.com/
HQ State/Province New Jersey
Sector Healthcare
Industry Medical Devices
Equity Style Small Cap/Blend
Next Earnings Release Nov. 02, 2022 (est.)
Last Earnings Release Jul. 27, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
IBRN 175406.0 USD 3.81%
CIPSX 64.84M USD 2.56%
SCSMX 84.55M USD 2.04%
CBMCX 10.64M USD 2.01%
FDHT 192924.0 USD 1.94%
JGMCX 123.99M USD 1.67%
HTEC 1.524M USD 1.55%
HMVUX 13.74M USD 1.51%
JVTCX 38.52M USD 1.26%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter IART Tweets